PofoliaShared via Pofolia

Journal of Magnetic Resonance Imaging· 2026Q1

MRI Proton Density Fat Fraction as a Biomarker of Marrow Recovery Following Organ‐Sparing Total Marrow Irradiation in Sickle Cell Disease

Malakeh Malekzadeh, Hemendra Ghimire, Ji Eun Lim, Srideshikan S. Madabushi et al.

Short summary

MRI-derived proton density fat fraction (PDFF) shows partial restoration of marrow fat in sickle cell disease (SCD) mice after organ-sparing total marrow irradiation (OS-TMI/BMT) and demonstrates initial feasibility in human patients.

AI-generated from the title and abstract; the full text is not read.

Key points

  • MRI-derived PDFF showed significantly higher marrow fat content in OS-TMI/BMT treated SCD mice compared to controls in proximal metaphysis (42.5% vs 34.8%), midshaft diaphysis (44.8% vs 26.9%), and distal metaphysis (45.1% vs 36.2%).
  • OS-TMI/BMT treatment in mice improved trabecular bone structure, including increased thickness and bone volume density.
  • In two human SCD patients, PDFF increased post-transplant, and one patient showed trilineage hematopoiesis without fibrosis on biopsy one year later.
  • PDFF mapping was performed using spoiled gradient echo multi-echo sequences at preclinical 7-T and clinical 3-T MRI.

AI-generated from the title and abstract; the full text is not read.

Abstract

BACKGROUND: Noninvasive quantitative assessment of marrow recovery after curative therapies such as total marrow irradiation (TMI) and bone marrow transplantation (BMT) remain poorly defined, particularly in sickle cell disease (SCD). PURPOSE: To evaluate MRI-derived proton density fat fraction (PDFF) as a biomarker of marrow recovery following organ-sparing total marrow irradiation-based transplantation (OS-TMI/BMT) in an SCD mouse model and to assess initial clinical feasibility in patients. STUDY TYPE: Exploratory preclinical study with descriptive pilot feasibility analysis in humans. SUBJECTS: Townes SCD mice (n = 10 controls, n = 8 treated) and 2 adults (male, 24 ± 1 years old) with SCD. FIELD STRENGTH/SEQUENCE: Preclinical 7-T small-bore MRI used a spoiled gradient echo (GRE) multi-echo sequence for PDFF and R2* mapping, while clinical 3-T MRI employed a spoiled GRE-based sequence. ASSESSMENT: Marrow recovery in an animal study was assessed using MRI-derived PDFF with ROI analysis, complemented by micro-CT and histologic evaluation. Translational feasibility was assessed with longitudinal PDFF MRI in 2 adults with severe SCD undergoing marrow transplantation. STATISTICAL TESTS: Parametric data were analyzed using t-tests and Pearson correlation, nonparametric data using Mann-Whitney U and Spearman correlation, and two-way ANOVA assessed group, region, and interaction effects, with significance set at p < 0.05. RESULTS: Right femur MRI showed partial restoration of adipose-rich marrow in the OS-TMI/BMT group versus controls, higher PDFF in the proximal metaphysis (42.5 ± 2.7 vs. 34.8 ± 6.5), midshaft diaphysis (44.8 ± 3.0 vs. 26.9 ± 7.0), and distal metaphysis (45.1 ± 2.6 vs. 36.2 ± 4.9). OS-TMI/BMT also improved trabecular structure, with increased trabecular thickness, reduced bone surface-to-volume ratio, lower structure model index and anisotropy, and increased distal bone volume density. In 2 patients, PDFF increased post-transplant, and 1-year biopsy showed trilineage hematopoiesis without fibrosis. DATA CONCLUSION: Marrow-selective transplantation was associated with partial normalization of the marrow and skeletal microenvironment in SCD. PDFF may provide a practical noninvasive approach for monitoring post-transplant marrow recovery. TECHNICAL EFFICACY: Stage 2.

The authors' abstract, as published at the source. Journal of Magnetic Resonance Imaging, 2026 · DOI ↗

TakeawaysPremium
Ask the paperFree account

Continue with a free account

Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.

Continue free on the web

Sign in with Google or Apple; no card needed. You come back to this paper.

On your phone:

Field: Genetics (Medicine)

GeneticsMedicine